Abstract
The emergence of more virulent and epidemic strains of viruses, especially in the context of COVID-19, makes it more important than ever to improve methods of decontamination. The objective of this study was to evaluate the potential of on-demand production of chlorine species to inactivate human coronaviruses. The commercial prototype disinfection unit was provided by Unipolar Water Technologies. The Unipolar device generates active chlorine species using an electrochemical reaction and dispenses the disinfectant vapour onto surfaces with an aspirator. The minimum effective concentration and exposure time of disinfectant were evaluated on human hepatoma (Huh7) cells using 50% tissue culture infectious dose (TCID50) assay and human coronavirus 229E (HCoV-229E), a surrogate for pathogenic human coronaviruses. We showed that chlorine species generated in the Unipolar device inactivate HCoV-229E on glass surfaces at ≥ 400 parts per million active chlorine concentration with a 5 min exposure time. Here, inactivation refers to the inability of the virus to infect the Huh7 cells. Importantly, no toxic effect was observed on Huh7 cells for any of the active chlorine concentrations and contact times tested.
Introduction
The emergence of more virulent and epidemic strains of virus, especially in light of the recent COVID-19 pandemic, makes it important to improve methods of decontamination1,2. Automated room disinfection (ARD) systems are used to sterilise contaminated surfaces with minimal assistance from human operators and have been developed to improve both the efficacy and reliability of hospital disinfection3,4,5,6,7. Vapour-generating ARD systems are important as they limit human error and generate fine mists that can cover, penetrate and disinfect complex surfaces8. This study investigated the use of the Unipolar Water Technologies ARD system for its effectiveness in the disinfection of the SARS-CoV-2 surrogate, HCoV-229E. The Unipolar Water Technologies ARD system operates by electrochemical generation of active chlorine species such as aqueous hypochlorous acid which are then dispensed in vapour form with an aspirator (Fig. 1).
Vaccines are a powerful measure to protect human health against pathogenic viruses, yet there is a significant challenge in achieving global population immunization against highly pathogenic coronavirus diseases because of vaccine efficacy, logistics, and availability problems9. Anti-viral treatments are not always fully effective10,11. In the absence of enough vaccines and effective therapeutic agents, protective measures such as mask-wearing12 and viral disinfection are important13. Human coronaviruses such as SARS-CoV-2 and HCoV-229E are transmitted through exposure to a cough or sneeze, inhalation of aerosolized virus, and through contact of contaminated surfaces14,15,16. The persistence of human coronaviruses on inanimate surfaces varies from a few minutes to days14,17,18,19 and contact between contaminated surfaces and hands with mucus membranes is a source of indirect transmission for coronaviruses17 and other viruses such as Ebolaviruses20. Effective surface disinfection may help ensure early containment and prevent further viral spread21. For these reasons, there has been a growing interest in developing more effective surface decontamination methods22 and improving the standard of disinfection to eliminate the increased risk of infection23,24,25. The minimum effective concentration and exposure time required for action of a disinfectant are the main factors in assessing its effectiveness against coronavirus and surrogate viruses26. HCoV-229E and murine hepatitis viruses are recommended viruses to study the efficacy of a disinfectant on hard surfaces and medical devices27,28. Huh7 cell lines are preferred by many researchers for these studies in assessing viral infection29,30, with the 50% tissue culture infectious dose assay used to quantify virus titre, infectivity, and effectiveness of the disinfectant31. The 50% tissue culture infectious dose value represents the number of viral particles needed to produce cytopathic effects in 50% of the cell culture or wells containing the treated cell culture after a defined period32.
Previous studies have shown that vapour-generating ARD systems provide an effective means to disinfect large spaces such as hospitals, nursing homes and quarantine facilities33. ARD systems have been demonstrated as effective means to decontaminate rooms34,35, multibed bays34,36,37 and entire units34,38,39 during outbreaks of Clostridioides difficile40, Acinetobacter baumannii41,42, methicillin-resistant Staphylococcus aureus and methicillin‐susceptible S. aureus36,39,43, multidrug‐resistant Gram‐negative bacteria37,38,44, and viruses including Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Lassa virus45,46,47. They have been demonstrated to successfully mitigate the risk posed from prior room occupancy24,34,48,49,50. These systems have recently been investigated for their potential to combat COVID-1951. Although these systems typically use H2O2, a recent report suggested that the use of cold vapour from a 1% sodium hypochlorite solution is more effective than other disinfection strategies being used to inactivate SARS-Cov-28. The World Health Organization also recommends the use of chlorinated disinfectant solutions52, which are high-efficacy disinfectants with a low chlorine concentration27.
This study aimed to evaluate the effect of an active chlorine-containing vapour on HCoV-229E. The ARD device tested generates active chlorine solutions on demand, and then dispenses the disinfectant vapour using an aspirator. Key objectives of the study were to characterize the disinfectant produced in this device, understand how vapour generation influences active chlorine concentration, and establish the exposure time required for inactivation of the SARS-CoV-2 surrogate, HCoV-229E.
Materials and methods
Active chlorine concentration analysis
An aqueous solution of methyl orange (14 ppm) and potassium bromide (100 ppm) was prepared, and all testing was carried out in open air at 20 °C. Five mL of this solution was transferred into a 20 mL glass vial. To this solution, 0.5 mL of the disinfectant solution was added. The absorbance of the sample at 469 nm was then measured using a spectrophotometer. If the absorbance was below 0.1 (indicating complete consumption of the methyl orange by reaction with active chlorine), the experiment was repeated with a more dilute sample. The absorbance at 469 nm was then used to determine the concentration of active chlorine based on a calibration curve. An equimolar reaction between methyl orange and active chlorine species is assumed in this assay.
Automated room disinfectant (ARD) system
The ARD system used in this study was provided by Unipolar Water Technologies53. This device generates active chlorine species using electrolysis of aqueous solutions of sodium chloride. The Unipolar ARD system then converts the bulk disinfectant solution into a vapour that is dispersed onto a target. The active chlorine concentration produced by this device can be altered by changing the initial NaCl(aq) concentration, the applied current or the run time. The device is filled with 5.5 L of NaCl(aq) solution of a desired concentration, and all sampling can be done through the outlet valve in the main reservoir at the bottom of the device (Fig. 1).
Virus propagation
Viral propagation and application of active chlorine treatment were adapted from protocols previously described54,55. Briefly: 1 mL Huh7 suspension (1.3 × 106 cells/mL) was mixed with 8 mL Dulbecco’s Modified Eagle Medium (DMEM) and 1 mL foetal bovine serum (FBS). The mixture was incubated at 37 °C with 5% CO2 in a sterile 75 mL cell culture flask. When ≥ 90% confluent cell growth was observed, the Huh7 culture was infected by HCoV-229E (3 × 106 TCID50 units/mL) and incubated for 5 days or until ≥ 90% of the culture showed cytopathic effect. Then, serum-free DMEM was added to the culture flask, and cells were harvested using a cell scraper and shaking. The suspension was centrifuged at 1000×g for 15 min. The pelleted cells were collected with serum-free DMEM and subjected to three rapid freeze–thaw cycles. The cell lysates were collected, mixed with 3 mL supernatant, aliquoted, and stored at −150 °C as crude virus samples; unpurified virus samples that may contain Huh7 host cells. Virus purification was carried out using the high purity™ lentivirus concentration kit (Creative Biogene, 45-1 Ramsay Road, Shirley, NY 11967, USA) following the manufacturer’s instructions. Virus stocks were quantified using 50% tissue culture infectious dose before use.
Treatment with active chlorine disinfectant (general procedure)
The Unipolar disinfectant vapour was applied using a method adapted from similar carrier methods54,56,57,58. A carrier method is a disinfection effect measurement test in which microorganisms are applied to the surface of a carrier (stainless steel, glass or polyvinyl chloride), dried, and then treated with a disinfectant59. Carrier methods more accurately reflect the applications in real-life clinical practice54. In summary: 35 µL of HCoV-229E crude virus sample (3 × 106 TCID50 units/mL) were put at the centre of a sterile 22 × 22 mm coverslip using a micropipette, gently spread all over the coverslip by the pipette tip and left at room temperature in a biosafety cabinet. Five minutes later, the coverslip containing the virus was transferred out of the biosafety cabinet and onto a glass stage placed on a bench within the lab, 18 cm away from the outlet of the Unipolar ARD device. Application of the disinfectant vapour (prepared at the specified concentration) onto the sample was then performed for varying amounts of time (referred to here as treatment time, ranging from 5 to 15 min). Note that in this case the treatment space is the volume of the room the samples are located within, however this experiment was also carried out by confining the treatment space into a smaller area (12,675 cm3). After application of the disinfectant mist, the sample was incubated further for varying amounts of time (referred to here as exposure time, ranging from 0 to 30 min). Following the exposure time, the coverslip was broken into smaller pieces and put in a 50 mL polypropylene tube containing 665 µL DMEM. Virus samples on the coverslip were suspended in the DMEM with careful shaking. Virus recovery was also made from sterile water-treated virus samples (treatment control groups) using the same procedure. Simultaneously, the effect of the disinfectant on the human cell line was checked. Accordingly, a coverslip in which only disinfectant vapour was applied with the same procedure was used to check the toxicity of the disinfectant on Huh7 cells. Toxicity was measured through the absence, presence, or degree of cytopathic effect. Ten-fold dilutions were made from each suspension in a 50 mL polypropylene tube and applied to each group of Huh7 cell cultures in 96-well tissue culture plates. Fifty microlitres of the suspension from each dilution was applied to at least eight wells containing ≥ 90% confluent Huh7 cell cultures and left on a rocking platform for an hour at room temperature. Then, 100 µL DMEM containing 10% foetal bovine serum was added to each well. Cultures treated with 50 µL of 10% foetal bovine serum—DMEM (FBS-DMEM) only were also used as the cell culture control group. The plates were then incubated for 5 days at 37 °C with 5% CO2. On day 6, the cultures were fixed with 100 µL of formaldehyde per well for ≥ 3 h. The formaldehyde was discarded, and cultures were stained with 50 µL 0.5% crystal violet per well for 30 min. Excess crystal violet was washed off using distilled water, and plates were air-dried and examined for cytopathic effects using an inverted microscope. Experiments were repeated three times with a minimum of three replicas each time unless indicated, and the mean is taken as a final result. This process is summarised in Fig. 2.
Determination of minimum effective concentration of disinfectant vapour
To determine the minimum effective disinfectant concentration, the general procedure described above was adopted and varied in the disinfectant concentration. First, 35 µL of HCoV-229E virus at 3 × 106 TCID50 units/mL was smeared on sterile 22 × 22 mm coverslips and left for five minutes at room temperature in a biosafety cabinet as above54,56,57,58. The coverslip containing the virus was transferred out of the biosafety cabinet and onto a glass stage placed on a bench in the lab before being contained in a smaller space by placing a large container with an opening on one side over the samples. The smeared virus samples were then treated with the disinfectant vapour with active chlorine concentrations of 200, 400, or 1000 parts per million (ppm) or sterile water for 10 min of treatment time using the Unipolar ARD at an 18 cm distance from the tip of the device’s nozzle to the target. After treatment, the samples were left at room temperature in a biosafety cabinet for an exposure time of an additional 10 min before they were processed as above. This experiment was repeated three times with three replicas each time.
Determination of minimum effective exposure time of disinfectant vapour
To determine the minimum exposure time for the Unipolar disinfectant vapour to inactivate HCoV-229E virus, the general procedure described above was adopted and varied in exposure time for a disinfectant concentration of 400 ppm active chlorine. Accordingly, 35 µL of HCoV-229E at 3 × 106 TCID50 units/mL concentration smeared on sterile 22 × 22 mm coverslips was left in a biosafety cabinet for 5 min at room temperature, in accordance with published protocols54,56,57,58. The coverslip containing the virus was transferred out of the biosafety cabinet and onto a glass stage on a bench in the lab before being contained in a smaller space by placing a large square plastic container (12,675 cm3) with an opening on one side over the samples. The virus samples were then treated with the disinfectant vapour containing 400 ppm active chlorine or sterile water (negative control) for treatment times of 10 min, after which they were transferred into the biosafety cabinet and left at room temperature for exposure times of 0-, 2-, 5-, 10-, 20-, and 30-min. At the end of each exposure time, samples were collected in DMEM and processed as described above.
Results and discussion
Active chlorine quantification method
To quantitatively monitor the active chlorine generated by the Unipolar ARD, a rapid, dye-based method was developed. Treatment of methyl orange dye with the Unipolar disinfectant solution or vapour results in decolouration that can be quantified using UV/Vis spectroscopy. The absorbance was monitored at the isosbestic point (469 nm) for methyl orange to control for its pH-dependent absorbance60,61. Degradation of methyl orange using Unipolar disinfectant solution or vapour requires longer than 30 min to reach completion, however this reaction can be accelerated by the addition of KBr (100 ppm) (Fig. 3A). The KBr reacts with active chlorine species to generate more reactive hypobromous acid in situ62. The presence of KBr did not influence the UV/Vis absorbance at 469 nm, allowing for the instantaneous determination of active chlorine concentration. It was also important to note that this method was selective for active chlorine and was unaffected by the presence of H2O2. Using this strategy, a calibration curve was created through the addition of 0.5 mL of various concentrations of disinfectant solution to 5.0 mL of an aqueous solution containing 14.3 ppm methyl orange and 100 ppm KBr and recording the absorbance at 469 nm (Fig. 3B).
Active chlorine quantification of the Unipolar ARD device
The Unipolar ARD device was used to produce active chlorine-containing disinfectant under varying sodium chloride concentrations and current. The active chlorine production in the solution reservoir was monitored over time using the methyl orange dye assay described above. Increasing the NaCl(aq) concentration or the applied current increased the rate of active chlorine production as expected (Fig. 4A, B). Using this information, it was possible to tailor the run-time and NaCl(aq) concentration of the initial solution to achieve a final solution with a desired active chlorine concentration of up to approximately 400 ppm in 20 min. To achieve concentrations of active chlorine up to 1000 ppm using an initial NaCl(aq) concentration of 1.0 M, the run time was increased to approximately 1 h at 2.0 A or 30 min when the amperage was increased to 3.0 A (Fig. 4C). This control is useful for ARD devices so that the disinfectant concentration can be tuned as required.
After electrolysis was complete, approximately 6 min were required to equilibrate the active chlorine concentration across the Unipolar ARD system. This equilibration is achieved by circulating the solution through the reservoir and electrode chambers with a pump operating at a flow rate of 4.5 L/min (Fig. 1). With this data and the concentration studies summarised in Fig. 2, the concentration of active chlorine in the disinfectant solution could be controlled. With that said, when this solution is converted into a vapour with the Unipolar aspirator, some of the active chlorine is lost due to volatilisation of chlorine species63,64,65. The active chlorine concentration in the reservoir is therefore the maximum active chlorine concentration in the resulting vapour. The effects of the distance and height from the sample as well as the size of the space the sample is contained within, on the distribution of the disinfectant were investigated. The treatment space and the setup of the experiment is described in Fig. 5A. Accordingly, an aqueous solution containing 14.3 ppm methyl orange and 100 ppm KBr was added to each well of 6 × 96 well plates. The plates were arranged in two rows of three with the long sides of each column next to each other. The Unipolar ARD was then placed in front of the plates and the vapour was dispersed across the sample area. The UV/Vis absorbance at 469 nm was then recorded for each well and the relative absorbance values were plotted as a colour map shown in Fig. 5. The distribution was uniform regardless of whether the device was placed at different heights and distances relative to the samples. The major difference observed occurred due to reducing the volume of the treated space (Fig. 5B). By reducing the volume of the treatment space, a higher rate of reaction (and disinfection when applied to virus samples) was observed across the samples. This demonstrates how efficiency of the surface treatment is proportional to the size of the space the vapour is dispersed within.
Testing the unipolar ARD device for HCoV-229E virus inactivation
Effect of treatment space on HCoV-229E disinfection efficiency
To test the efficacy of the Unipolar ARD device against coronaviruses on hard surfaces, HCoV-229E was used as a model virus27. Based on a recently published European standard, titre reduction of coronaviruses due to effective disinfection must be at least 10,000-fold54,66. Virucidal activity of the chlorine-based disinfectant in this study was determined by the difference in logarithmic titre of the virus between control and treatment groups, referred to as reduction factor. A reduction factor of ≥ 4 was regarded as evidence of sufficient virucidal activity21,56. Initially, experiments were performed using a reservoir concentration of 400 ppm active chlorine, with exposure times of 1, 5 and 15 min, but minimal virus inactivation was observed in the larger treatment space. Therefore, the 15-min exposure time was then repeated but this time the samples were confined in a smaller treatment space (12,675 cm3). These initial experiments confirmed the effect of the size of the treatment space on treatment efficiency observed in dye experiments with virus inactivation only observed when the surface contaminated with the virus was confined in a smaller treatment space. Using a reservoir concentration of 400 ppm active chlorine, 100-fold inactivation of crude HCoV-229E was achieved in a confined space, whereas without space confinement, the level of inactivation was not significant. Under these conditions, the disinfectant vapour was also not toxic to Huh7 cells. These results were encouraging and prompted further tests to evaluate the effects of active chlorine concentration and exposure time on HCoV-229E inactivation efficiency. All the following experiments were performed in a confined space to ensure factors such as airflow and ventilation could be held constant between tests.
Minimum effective concentration of active chlorine for HCoV-229E disinfection
Next, treatment and exposure times were held at 10 min and the effect of active chlorine concentration was investigated. First, disinfectant vapour was generated from the Unipolar reservoir containing concentrations of 200, 400 and 1000 ppm active chlorine. Each concentration was evaluated for its effectiveness towards inactivation of HCoV-229E virus on the surface of a carrier material. The results revealed that both 400 and 1000 ppm active chlorine showed effective (> 4 log10) inactivation of HCoV-229E virus on carrier whereas insignificant (1.2 log10) virus inactivation occurred at 200 ppm active chlorine (Table 1).
Based on these results, 400 ppm active chlorine was chosen as the concentration to be used for further testing. It should be noted that testing virucidal activity of disinfectants using a carrier method imitates real-world conditions encountered in surface contamination. As such, concentration and action times are usually much more than those obtained with suspension methods67. Therefore, the findings of this study can also be used for disinfecting suspensions as viruses in suspensions are easier to inactivate than viruses on surfaces54.
Effective exposure time for HCoV-229E disinfection
Next, the effect of exposure time on HCoV-229E virus inactivation was investigated. HCoV-229E samples were treated with active chlorine at a concentration of 400 ppm concentration and after application of the disinfectant mist, the samples were incubated further with exposure times of 0, 2, 5, 10, 20 and 30 min. All exposure times showed a decrease in TCID50, but a significant reduction was observed at exposure times 5 min and longer. This result indicates that active chlorine is effective in inactivating HCoV-229E with 400 ppm concentration within 5 min of exposure after application of the disinfectant. Figure 6A shows crystal violet stained Huh7 cell cultures in 96-well plates treated for 5 days with active chlorine-treated viruses (left 6 columns) and water-treated viruses (right 6 columns) using 5-min exposure times. High TCID50 units in log10/mL of HCoV-229E were recovered across all exposure periods from water-treated samples (Fig. 6B, red line). In contrast, a significant decrease in TCID50 units in log10/mL of HCoV-229E was observed in samples in which the virus was treated with the Unipolar-generated active chlorine (Fig. 6B, green line). The virus reduction after 5 min of exposure was at least 4.2 log10 compared to water-treated groups. On the contrary, samples treated with active chlorine at 0- and 2-min exposure showed less virus reduction (≤ 1.5 log10). These results can be seen in Fig. 6.
The results in Fig. 6 indicate that the minimum exposure time required for viral inactivation using the Unipolar ARD device is 5 min at its minimum effective concentration of active chlorine (400 ppm). It is important to note that any decrease in TCID50 units of HCoV-229E beyond 20 min exposure time might be partly due to the dryness effect on the viral sample over time, which is supported by a previous similar study68. It is notable that other studies have specified active chlorine concentrations of 2000 ppm or more are required to achieve significant viral load reductions in households and healthcare facilities13,17. However, more recent studies have demonstrated that 1000 ppm sodium hypochlorite concentration is effective in treating coronaviruses in only one minute19. The World Health Organisation also recommends the use of a chlorinated disinfectant concentration of at least 1000 ppm to be effective on surfaces within a few minutes52. The results for longer exposure time in this study are similar to the results of the previous studies and align with the World Health Organisation recommendations for liquid disinfectants, as using higher chlorinated disinfectant concentrations will decrease the exposure time required for successful inactivation of HCoV-229E27,67. This study achieves effective inactivation of HCoV-229E on a carrier at a significantly lower chlorinated disinfectant concentration of 400 ppm in only 5 min of exposure time. The efficacy of this method at lower concentrations and short exposure times is an advantage over previous studies, as it reduces the potential toxicity on humans and animals, conserves disinfectant, and enables longer operation time52.
It was also demonstrated in this study that the Huh7 cell cultures treated with active chlorine only (no virus) did not show cytopathic effects. This was true for all concentrations of chlorine disinfectant investigated. The absence of cytopathic effects suggests that the active chlorine concentrations used were not toxic to Huh7 cells. This is an important finding as cytotoxicity of chlorine bleach-based disinfectants has been observed at active chlorine concentrations of 800 ppm or higher at ≥ 2 min exposure times on human peripheral lymphocytes69, dermal fibroblasts70, ocular melanoma cells71, and osteoblasts72. More generally, toxicity to human cells is less of a concern for disinfection of unoccupied spaces, which is of relevance for decontamination of hospital wards, public facilities, shipping containers and quarantine areas.
Conclusion
A rapid method for analysing the active chlorine concentration was established and used to optimize disinfectant vapour generated from the Unipolar ARD system. This disinfectant vapour was established as effective for inactivation of HCoV-229E virus on surfaces of carriers using low chlorine concentrations and short exposure times. With exposure times of 5 min at 400 ppm active chlorine, significant viral inactivation was observed, with no apparent toxic effect on Huh7 cells. This is the lowest effective chlorine disinfectant concentration reported in the literature for effective inactivation of coronavirus in short exposure times. The rapid, on-demand generation of disinfectants bodes well for virus inactivation on surfaces. Future studies will extend this evaluation to other viral and bacterial pathogens and biofilms, with potential applications for disinfection in public, domestic, healthcare, and industrial settings.
Data availability
The datasets generated and analysed during the current study available from the corresponding author on reasonable request.
References
-
Dubberke, E. R. et al. Prevalence of Clostridium difficile environmental contamination and strain variability in multiple health care facilities. Am. J. Infect. Control. 35, 315–318 (2007).
Google Scholar
-
Peleg, A. Y. & Hooper, D. C. N. Hospital-acquired infections due to gram-negative bacteria. Engl. J. Med. 362, 1804–1813 (2010).
Google Scholar
-
Otter, J. A. Yezli, S., Barbut, F., Perl, T. M. An overview of automated room disinfection systems: When to use them and how to choose them in Decontamination in Hospitals and Healthcare (Second Edition) (ed. Walker, J.) 323–369 (Woodhead publishing, 2020).
-
Rutala, W. A. & Weber, D. J. Are room decontamination units needed to prevent transmission of environmental pathogens. Infect. Control. Hosp. Epidemiol. 32, 743–747 (2011).
Google Scholar
-
Davies, A., Pottage, T., Bennett, A. & Walker, J. Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment. J. Hosp. Infect. 77, 199–203 (2011).
Google Scholar
-
Falagas, M. E. et al. Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J. Hosp. Infect. 78, 171–177 (2011).
Google Scholar
-
Byrns, G. & Fuller, T. P. The risks and benefits of chemical fumigation in the health care environment. J. Occup. Environ. Hyg. 8, 104–112 (2011).
Google Scholar
-
Gupta, A. et al. Disinfection by 1% sodium hypochlorite through cold fogging: an innovative appropriate technology against COVID-19 in public health Int. J. Res. Med. Sci. 10, (2022).
-
Altmann, D. M. Boyton, COVID-19 vaccination: The road ahead. R. J. Sci. 375, 1127–1132 (2022).
Google Scholar
-
Bergman, S., Cennimo, D. J., Miller, M. M. Olsen, K. M. Medscape. 1–49 (2021).
-
World Health Organization (WHO), Theraputics and Covid-19 https://www.who.int/teams/health-care-readiness/covid-19/therapeutics (2021)
-
Prather, K. A., Wang, C. C. & Schooley, R. T. Reducing transmission of SARS-CoV-2. Science. 368, 1422–1424 (2020).
Google Scholar
-
Saadatpour, F. & Mohammadipanah, F. Physicochemical susceptibility of SARS-CoV-2 to disinfection and physical approach of prophylaxis. Health Sci. Rep. 3, e213 (2020).
Google Scholar
-
Akram, M. Z. Inanimate surfaces as potential source of 2019-nCoV spread and their disinfection with biocidal agents. Virusdisease. 31, 94–96 (2020).
Google Scholar
-
Blondin-Brosseau, M., Harlow, J., Doctor, T. & Nasheri, N. Examining the persistence of human Coronavirus 229E on fresh produce. Food Microbiol. 98, 103780 (2021).
Google Scholar
-
Greenhalgh, T. et al. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 397, 1603–1605 (2021).
Google Scholar
-
Kampf, G. Potential role of inanimate surfaces for the spread of coronaviruses and their inactivation with disinfectant agents. Infect. Prev.. Pract. 2, 100044 (2020).
Google Scholar
-
Warnes, S. L. Little, Z. R., Keevil, C. W. Human coronavirus 229E remains infectious on common touch surface materials. mBio. 6, e01697–15 (2015).
-
Kampf, G., Todt, D., Pfaender, S. & Steinmann, E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J. Hosp. Infect. 104, 246–251 (2020).
Google Scholar
-
Jacob, S. T. et al. Ebola virus disease. Nat. Rev. Dis. Primers. 6, 13 (2020).
Google Scholar
-
Huang, Y., Xiao, S., Song, D. & Yuan, Z. Evaluating the virucidal activity of four disinfectants against SARS-CoV-2. Am. J. Infect. Cont. 50, 319–324 (2022).
Google Scholar
-
Castano, N. et al. Fomite transmission, physicochemical origin of virus-surface interactions, and disinfection strategies for enveloped viruses with applications to SARS-CoV-2. ACS Omega. 6, 6509–6527 (2021).
Google Scholar
-
Anderson, D. J. et al. Enhanced terminal room disinfection and acquisition and infection caused by multidrug-resistant organisms and Clostridium difficile (the Benefits of Enhanced Terminal Room Disinfection study): A cluster-randomised, multicentre, crossover study. Lancet. 389, 805–814 (2017).
Google Scholar
-
Passaretti, C. L. et al. An evaluation of environmental decontamination with hydrogen peroxide vapor for reducing the risk of patient acquisition of multidrug-resistant organisms. Clin. Infect Dis. 56, 27–35 (2013).
Google Scholar
-
Datta, R., Platt, R., Yokoe, D. S. & Huang, S. S. Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. Arch. Intern. Med. 171, 491–494 (2011).
Google Scholar
-
Lin, Q. et al. Sanitizing agents for virus inactivation and disinfection. View 1, e16 (2020).
Google Scholar
-
Xiling, G. et al. In vitro inactivation of SARS-CoV-2 by commonly used disinfection products and methods. Sci. Rep. 11, 1–9 (2011).
-
Blondin-Brosseau, M., Harlow, J., Doctor, T. & Nasheri, N. Examining the persistence of human Coronavirus 229E on fresh produce. Food. Microbiol. 98, 103780 (2021).
Google Scholar
-
Ramirez, S. et al. Overcoming culture restriction for SARS-CoV-2 in human cells facilitates the screening of compounds inhibiting viral replication. Antmicrob. Agents Chemother. 65, e00097-e121 (2021).
Google Scholar
-
Zhao, J. et al. Cell morphological analysis of SARS-CoV-2 infection by transmission electron microscopy. J. Thorac. Dis. 12, 4368 (2020).
Google Scholar
-
Bullen, C. K., Davis, S. L., Looney, M. M., Quantification of infectious SARS-CoV-2 by the 50% tissue culture infectious dose endpoint dilution assay. In SARS-CoV-2, Springer: 2022, pp. 131–146.
-
Lei, C., Yang, J., Hu, J. & Sun, X. On the calculation of TCID50 for quantitation of virus infectivity. Virologica Sinica. 36, 141–144 (2021).
Google Scholar
-
Mittal, R., Ni, R. & Seo, J.-H. The flow physics of COVID-19. J. Fluid Mech. 894, F2 (2020).
Google Scholar
-
Boyce, J. M. et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. J. Infec. Control Hosp.l Epidemiol. 29, 723–729 (2008).
-
French, G. L. et al. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): A comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J. Hosp. Infect. 57, 31–37 (2004).
Google Scholar
-
Dryden, M. et al. Hydrogen peroxide vapour decontamination in the control of a polyclonal meticillin-resistant Staphylococcus aureus outbreak on a surgical ward. J. Hosp. Infect. 68, 190–192 (2008).
Google Scholar
-
Bates, C. & Pearse, R. Use of hydrogen peroxide vapour for environmental control during a Serratia outbreak in a neonatal intensive care unit. J. Hosp. Infect. 61, 364–366 (2005).
Google Scholar
-
Otter, J. A. et al. Hydrogen peroxide vapor decontamination of an intensive care unit to remove environmental reservoirs of multidrug-resistant gram-negative rods during an outbreak. Am. J. Infect. Control. 38, 754–756 (2010).
Google Scholar
-
Jeanes, A., Rao, G., Osman, M. & Merrick, P. Eradication of persistent environmental MRSA. J. Hosp. Infect. 61, 85–86 (2005).
Google Scholar
-
Cooper, T., O’Leary, M., Yezli, S. & Otter, J. Impact of environmental decontamination using hydrogen peroxide vapour on the incidence of Clostridium difficile infection in one hospital Trust. J. Hosp. Infect. 78, 238–240 (2011).
Google Scholar
-
Ray, A. et al. Use of vaporized hydrogen peroxide decontamination during an outbreak of multidrug-resistant acinetobacter baumannii infection at a Long-Term Acute Care Hospital. Infect. Control. Hosp. Epidemiol. 31, 1236–1241 (2010).
Google Scholar
-
Chmielarczyk, A. et al. Control of an outbreak of Acinetobacter baumannii infections using vaporized hydrogen peroxide. J. Hosp. Infect. 81, 239–245 (2012).
Google Scholar
-
Otter, J. Davies, B. Klein, J., Watts, T. Kearns, A. French, G. In Identification and Control of an Outbreak of Gentamicin-Resistant, Methicillin-Susceptible Staphylococcus Aureus on a Neonatal Unit (13th International symposium on staphylococci and staphylococcal infection 2008).
-
Kaiser, M. Elemendorf, S. Kent, D. Evans, A. Harrington, S. McKenna, D. In Management of a Multi-year MDR Acinetobacter baumannii Outbreak in the ICU Setting, (Infectious Diseases Society of America Annual Meeting. Abstract, 2011).
-
Schinköthe, J. et al. Airborne disinfection by dry fogging efficiently inactivates severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2), mycobacteria, and bacterial spores and shows limitations of commercial spore carriers. Appl. Environ. microbiol. 87, e02019-e2020 (2021).
Google Scholar
-
Otter, J. et al. Hydrogen peroxide vapour decontamination of a critical care unit room used to treat a patient with Lassa fever. J. Hosp. Infect. 75, 335–337 (2010).
Google Scholar
-
Urushidani, M. et al. Inactivation of SARS-CoV-2 and influenza A virus by dry fogging hypochlorous acid solution and hydrogen peroxide solution. PloS one. 17, e0261802 (2022).
Google Scholar
-
Manian, F. A., Griesnauer, S. & Bryant, A. Implementation of hospital-wide enhanced terminal cleaning of targeted patient rooms and its impact on endemic Clostridium difficile infection rates. Am. J. Infect. Control. 41, 537–541 (2013).
Google Scholar
-
McCord, J., Prewitt, M., Dyakova, E., Mookerjee, S. & Otter, J. Reduction in Clostridium difficile infection associated with the introduction of hydrogen peroxide vapour automated room disinfection. J. Hosp. Infect. 94, 185–187 (2016).
Google Scholar
-
Horn, K. & Otter, J. A. Hydrogen peroxide vapor room disinfection and hand hygiene improvements reduce Clostridium difficile infection, methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and extended-spectrum β-lactamase. Am. J. Infect. Control. 43, 1354–1356 (2015).
Google Scholar
-
Wood, J. P. et al. Evaluation of electrostatic sprayers and foggers for the application of disinfectants in the era of SARS-CoV-2. PloS one. 16, e0257434 (2021).
Google Scholar
-
World Health Organization, Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts: interim guidance, (2020).
-
Gomez, R. 2006. Electrolytic activation of water, Australia, WO2007140544. Priority application AU2007257247B2, priority date 9 June 2006.
-
Tarka, P. & Nitsch-Osuch, A. Evaluating the virucidal activity of disinfectants according to European Union Standards. Viruses. 13, 534 (2021).
Google Scholar
-
Cell Culture Basics Handbook. Thermo Fisher Scientific. https://assets.thermofisher.com/TFS-Assets/BID/Handbooks/gibco-cell-culture-basics-handbook.pdf (2020)
-
Rabenau, H. F. et al. Guideline for testing chemical disinfectants regarding their virucidal activity within the field of human medicine. Springer: 63, 645 – 655 (2020).
-
Becker, B. et al. Evaluation of the virucidal efficacy of disinfectant wipes with a test method simulating practical conditions. Antimicrob Resist. Infect. Control. 8, 121 (2019).
Google Scholar
-
Bonny, T. S., Yezli, S. & Lednicky, J. A. Isolation and identification of human coronavirus 229E from frequently touched environmental surfaces of a university classroom that is cleaned daily. Am. J. Infect. Control. 46, 105–107 (2018).
Google Scholar
-
EN 17111:2018: Chemical Disinfectants and Antiseptics—Quantitative Carrier Test for the Evaluation of Virucidal Activity for Instruments Used in the Medical Area—Test Method and Requirements (Phase 2, Step 2). European Committee for Standardization Brussels, Belgium (2018).
-
Barbosa, J. INDICATORS | Acid–Base. In Encyclopedia of Analytical Science (Second Edition), Worsfold, P. Townshend, A. Poole, C. (Ed. Elsevier) 360–371 (2005).
-
Elmas, S. et al. Photometric sensing of active chlorine, total chlorine, and pH on a microfluidic chip for online swimming pool monitoring. Sensors. 20, 3099 (2020).
Google Scholar
-
Mann, M. Chalker, J. M. 2019. Materials and processes for recovering precious metals. Australia, WO2020198778. Priority Application AU2019901135, 3 April 2019.
-
Park, G. W., Boston, D. M., Kase, J. A., Sampson, M. N. & Sobsey, M. D. Evaluation of liquid- and fog-based application of sterilox hypochlorous acid solution for surface inactivation of human norovirus. Appl. Environ. Microbiol. 73, 4463–4468 (2007).
Google Scholar
-
Len, S. V. et al. Effects of storage conditions and pH on chlorine loss in electrolyzed oxidizing (EO) water. J Agric. Food Chem. 50, 209–212 (2002).
Google Scholar
-
McRay, R. J., Dineen, P. & Kitzke, E. D. Disinfectant fogging techniques. Soap Chem. Spec. 40, 112–114 (1964).
-
Eggers, M. et al. The European tiered approach for virucidal efficacy testing—rationale for rapidly selecting disinfectants against emerging and re-emerging viral diseases. Eurosurveillance. 26, 2000708 (2021).
Google Scholar
-
Rabenau, H. F., Steinmann, J., Rapp, I., Schwebke, I. & Eggers, M. Evaluation of a virucidal quantitative carrier test for surface disinfectants. PloS One. 9, e86128 (2014).
Google Scholar
-
Kurahashi, M., Ito, T. & Naka, A. Spatial disinfection potential of slightly acidic electrolyzed water. PloS one. 16, e0253595 (2021).
Google Scholar
-
Gül, S., Savsar, A. & Tayfa, Z. Cytotoxic and genotoxic effects of sodium hypochlorite on human peripheral lymphocytes in vitro. Cytotechnology. 59, 113–119 (2009).
Google Scholar
-
Hidalgo, E., Bartolome, R. & Dominguez, C. Cytotoxicity mechanisms of sodium hypochlorite in cultured human dermal fibroblasts and its bactericidal effectiveness. Chem. Biol. Interact. 139, 265–282 (2002).
Google Scholar
-
Missotten, G., Keijser, S. D. & Keizer, R. Cytotoxic effect of sodium hypochlorite 0.5% (NaOCl) on ocular melanoma cells in vitro. Orbit. 27, 31–35 (2008).
Google Scholar
-
Böhle, S. Cytotoxic effect of sodium hypochlorite (Lavanox 0.08%) and chlorhexidine gluconate (Irrisept 0.05%) on human osteoblasts. Euro. J. Orthop. Surg. Traumatol. 32, 81–89 (2022).
Google Scholar
Acknowledgements
The authors acknowledge the technical and financial support for this project provided by Rudolfo Gomez of Unipolar Water Technologies and RMG Hydrogen Technologies Pty. Ltd.
Biosafety statement
This research was approved by the Flinders University Biosafety Committee.
Author information
Authors and Affiliations
Contributions
N.L., S.E., Z.J., and J.C. designed and carried out electrochemical assays. L.K. and P.S. designed all biological assays and N.L. assisted with disinfection experiments. All authors evaluated data. N.L., L.K. and J.C. wrote the manuscript and all authors contributed to revisions.
Corresponding authors
Ethics declarations
Competing interests
This study was funded by Unipolar Water Technologies and RMG Hydrogen Technologies Pty. Ltd.. No authors have a financial stake in this company and act as independent researchers in the testing of the automated room disinfection device.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Reprints and Permissions
About this article
Cite this article
Lundquist, N.A., Kifelew, L.G., Elmas, S. et al. Inactivation of human coronaviruses using an automated room disinfection device.
Sci Rep 13, 20048 (2023). https://doi.org/10.1038/s41598-023-47082-z
-
Received: 03 August 2023
-
Accepted: 08 November 2023
-
Published: 16 November 2023
-
DOI: https://doi.org/10.1038/s41598-023-47082-z
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.